Figure 3.
OS after ibrutinib discontinuation. A) All cause discontinuation and B) stratified by reason for discontinuation (PD/no response versus other causes).

OS after ibrutinib discontinuation. A) All cause discontinuation and B) stratified by reason for discontinuation (PD/no response versus other causes).

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal